PAIN POINT — EXPERIMENTAL → AUTHORIZED

Research progresses through evidence and inspection — not directly into consequence.

SYNTHETIC / DEMONSTRATION
What you are looking at
IMPLEMENTED TODAY

GGKS Studio, the real governed research studio at research/ggks-studio/, genuinely implements inspect-before-execute and evidence/inference separation for synthetic genomic research requests.

ARCHITECTURE DEMONSTRATED

The six-stage progression control below (Prediction → Evidence → Inspection → Corroboration → Standing → Authorized Use) illustrates GGKS's own governed sequence using a bounded synthetic example.

INTEGRATION REQUIRED

This progression-tracking control is not a claim that a dedicated lifecycle UI already exists for it in GGKS Studio today (a future GGKS milestone, not yet built) — it is this scenario's own illustration of the sequence, honestly labeled as such.

A predictive model's synthetic-sandbox output is proposed for direct citation in a regulatory-facing filing — skipping the evidence, inspection and corroboration steps between "experimental" and "operational."

The situation

A prediction has been generated in a synthetic research sandbox. Someone proposes citing it directly in a regulatory-facing filing draft, before it has passed through the intervening governed steps.

What the model / agent knows

  • Its own synthetic prediction output.
  • Nothing about whether that output has since been evidenced, inspected, or corroborated — those are separate, later steps, not something the originating prediction step performs.

What it wants to do

Have its synthetic output cited as if it were already operational, authorized evidence.

Exact Action
Actor
The proposer (unnamed in this fixture)
Requested action
Cite the synthetic prediction as already-operational, authorized evidence
Target / system
Regulatory-facing filing draft
Scope
Bound to the progression stage actually reached
Context
Moving a claim from experimental to operational requires the intervening stages to be reached first, not skipped
Current permission
—

What capability it can access

Capability access
Prediction sandbox
Reachable — this is where the output originated
Regulatory filing draft
Reachable for citation, technically — governed use is a separate question

Who has authority?

Moving a claim from experimental to operational is not something a prediction step can authorize for itself. It requires the later stages below to actually be reached first.

Synthetic control — progression stage reached

What Genesis checks

  • Which stage of the progression has actually been reached.
  • Whether any stage is being skipped rather than passed through.
  • Whether "authorized use" specifically has been reached, not merely a nearby stage.
Current standing
Origin
Synthetic prediction, sandbox-only
Progression stage reached
Prediction
Evidence / provenance
NOT ESTABLISHED
Standing for operational/regulatory use
NOT ESTABLISHED
Current Permission
NOT AUTHORIZED

Only the Prediction stage has been reached. Citation in a regulatory-facing filing requires Authorized Use.

Reviewer Decision
NO REVIEWER DECISION FOR CURRENT STATE

What happens next

Genesis would evaluate each stage independently. Move the control through each one to see the demonstrated consequence boundary stay NOT AUTHORIZED until Authorized Use specifically is reached — it does not treat "further along" as good enough on its own.

Inspect the evidence

See the reasoning

This progression is drawn directly from GGKS Studio's own real, implemented framing (predict / evidence / inspect / corroborate / preserve / authorize) — this scenario names it consistently rather than inventing a competing sequence.